CCTV reported the clinical application of ACTL targeted anti-tumor immune technology

At 8 pm on April 9, 2012, the CCTV News Channel "Oriental Space-Time" column reported the first case of "targeted cellular immunotherapy" in Northeast China, marking the promise of ACTL targeted cellular immunotherapy. Promotion in tumor treatment.